Haemophilus ducreyi is the etiologic agent of chancroid. This sexually transmitted disease is predominantly found in developing countries, but it has been increasing in frequency in the United States. H. ducreyi has been implicated in the heterosexual transmission of Human Immunodeficiency Virus (HIV) in Africa. The pathogenicity and virulence of H. ducreyi remains poorly understood. Although only limited data exists concerning the lipooligosaccharides (LOS) of H. ducreyi, these studies suggest that the LOS may play an important role in the disease process. In a recent report, it has been shown that the typical lesions seen in the mouse model for H. ducreyi virulence can be produced by heat-killed organisms and purified LOS. The LOS of this organism has characteristics similar to other gram negative non-enteric mucosal pathogens, such as Neisseria meningitidis and Neisseria gonorrhoeae. Some strains of N. meningitidis and many strains of N. gonorrhoeae express an epitope(s) on their LOS that is immunochemically similar to a precursor of the human I erythrocyte antigen. This human antigen is found on red blood cells, neutrophils and in mucin. Our laboratory has recently demonstrated that this epitope(s) is present on the LOS of H. ducreyi. The organism may utilize these LOS epitopes as a form of molecular mimicry to evade host defense mechanisms.
The aim of this proposal is to test the hypothesis that the lipooligosaccharides (LOS) of Haemophilus ducreyi play an important role in the pathogenesis of chancroid. We believe that the oligosaccharide portion of the LOS contains epitopes which mimic human antigens and this mimicry may be an important factor in the ability of this organism to escape the immune response, while the lipid A moiety of the LOS is a primary factor in the cutaneous pathology of this infection. We will test these by: 1) Using monoclonal and polyclonal antibodies to define the antigenic and epitopic structure present on LOS's of H. ducreyi and to determine whether these antigens and epitopes play a role in molecular mimicry. 2) The elucidation of the mechanism mediating the biology effects of H. ducreyi LOS on the skin. 3) The development of isogenic LOS mutants from a wild type H. ducreyi strain by pyocin selection, chemical mutagenesis, or transposon insertion mutagenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI030006-02
Application #
3145053
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1991-09-30
Project End
1994-07-31
Budget Start
1992-09-01
Budget End
1993-07-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
State University of New York at Buffalo
Department
Type
Schools of Medicine
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Schilling, Birgit; Gibson, Bradford W; Filiatrault, Melanie et al. (2002) Characterization of lipooligosaccharides from Haemophilus ducreyi containing polylactosamine repeats. J Am Soc Mass Spectrom 13:724-34
Tullius, Michael V; Phillips, Nancy J; Scheffler, N Karoline et al. (2002) The lbgAB gene cluster of Haemophilus ducreyi encodes a beta-1,4-galactosyltransferase and an alpha-1,6-DD-heptosyltransferase involved in lipooligosaccharide biosynthesis. Infect Immun 70:2853-61
Filiatrault, M J; Munson Jr, R S; Campagnari, A A (2001) Genetic analysis of a pyocin-resistant lipooligosaccharide (LOS) mutant of Haemophilus ducreyi: restoration of full-length LOS restores pyocin sensitivity. J Bacteriol 183:5756-61
Young, R S; Filiatrault, M J; Fortney, K R et al. (2001) Haemophilus ducreyi lipooligosaccharide mutant defective in expression of beta-1,4-glucosyltransferase is virulent in humans. Infect Immun 69:4180-4
Filiatrault, M J; Gibson, B W; Schilling, B et al. (2000) Construction and characterization of Haemophilus ducreyi lipooligosaccharide (LOS) mutants defective in expression of heptosyltransferase III and beta1,4-glucosyltransferase: identification of LOS glycoforms containing lactosamine repeats. Infect Immun 68:3352-61
Palmer, K L; Thornton, A C; Fortney, K R et al. (1998) Evaluation of an isogenic hemolysin-deficient mutant in the human model of Haemophilus ducreyi infection. J Infect Dis 178:191-9
Gibson, B W; Campagnari, A A; Melaugh, W et al. (1997) Characterization of a transposon Tn916-generated mutant of Haemophilus ducreyi 35000 defective in lipooligosaccharide biosynthesis. J Bacteriol 179:5062-71
Melaugh, W; Campagnari, A A; Gibson, B W (1996) The lipooligosaccharides of Haemophilus ducreyi are highly sialylated. J Bacteriol 178:564-70
Spinola, S M; Orazi, A; Arno, J N et al. (1996) Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. J Infect Dis 173:394-402
Spinola, S M; Wild, L M; Apicella, M A et al. (1994) Experimental human infection with Haemophilus ducreyi. J Infect Dis 169:1146-50

Showing the most recent 10 out of 14 publications